110 related articles for article (PubMed ID: 16807369)
1. Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism.
Rumbaugh J; Turchan-Cholewo J; Galey D; St Hillaire C; Anderson C; Conant K; Nath A
FASEB J; 2006 Aug; 20(10):1736-8. PubMed ID: 16807369
[TBL] [Abstract][Full Text] [Related]
2. Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif.
Mishra M; Vetrivel S; Siddappa NB; Ranga U; Seth P
Ann Neurol; 2008 Mar; 63(3):366-76. PubMed ID: 18074388
[TBL] [Abstract][Full Text] [Related]
3. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A
Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650
[TBL] [Abstract][Full Text] [Related]
4. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
[TBL] [Abstract][Full Text] [Related]
5. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine.
Nath A; Haughey NJ; Jones M; Anderson C; Bell JE; Geiger JD
Ann Neurol; 2000 Feb; 47(2):186-94. PubMed ID: 10665489
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
Jiang MC; Lin JK; Chen SS
Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
[TBL] [Abstract][Full Text] [Related]
7. Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes.
Pocernich CB; Sultana R; Hone E; Turchan J; Martins RN; Calabrese V; Nath A; Butterfield DA
J Neurosci Res; 2004 Aug; 77(4):532-9. PubMed ID: 15264223
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
9. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.
Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C
J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986
[TBL] [Abstract][Full Text] [Related]
10. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat.
Bharucha DC; Zhou M; Nekhai S; Brady JN; Shukla RR; Kumar A
Virology; 2002 Apr; 296(1):6-16. PubMed ID: 12036313
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.
Rusnati M; Taraboletti G; Urbinati C; Tulipano G; Giuliani R; Molinari-Tosatti MP; Sennino B; Giacca M; Tyagi M; Albini A; Noonan D; Giavazzi R; Presta M
FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976
[TBL] [Abstract][Full Text] [Related]
12. The HIV-1 Tat transactivator protein: a therapeutic target?
Fulcher AJ; Jans DA
IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-1 induces cleavage of exogenous alphaB-crystallin transduced by a cell-penetrating peptide.
Yang SW; Lee SM; Choi EY; Lee KH; Kim SH; Shin MJ; Han YS; Kang SM; Chung JH
J Cell Biochem; 2011 Sep; 112(9):2454-62. PubMed ID: 21538481
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors.
Johnston JB; Zhang K; Silva C; Shalinsky DR; Conant K; Ni W; Corbett D; Yong VW; Power C
Ann Neurol; 2001 Feb; 49(2):230-41. PubMed ID: 11220743
[TBL] [Abstract][Full Text] [Related]
15. Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction.
Jeyapaul J; Seshamma T; Khan SA
Oncogene; 1991 Sep; 6(9):1507-13. PubMed ID: 1923518
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
17. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
[TBL] [Abstract][Full Text] [Related]
18. HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region.
Behnisch T; Francesconi W; Sanna PP
Brain Res; 2004 Jun; 1012(1-2):187-9. PubMed ID: 15158177
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress.
Kruman II; Nath A; Mattson MP
Exp Neurol; 1998 Dec; 154(2):276-88. PubMed ID: 9878167
[TBL] [Abstract][Full Text] [Related]
20. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport.
Chauhan A; Turchan J; Pocernich C; Bruce-Keller A; Roth S; Butterfield DA; Major EO; Nath A
J Biol Chem; 2003 Apr; 278(15):13512-9. PubMed ID: 12551932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
